Dynamic changes in circulating tumor cell levels as a prognostic marker in stage IV non-small cell lung cancer

被引：0
|
作者：
Carlsson, Anders
Bazhenova, Lyudmila
Kolatkar, Anand
Luttgen, Madelyn
Bethel, Kelly
Nieva, Jorge J.
Kuhn, Peter
机构：
[1] Scripps Res Inst, La Jolla, CA 92037 USA
[2] UC San Diego Moores Canc Ctr, La Jolla, CA USA
[3] Billings Clin Canc Ctr, Billings, MT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8109
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
    Obermayr, Eva
    Koppensteiner, Nina
    Heinzl, Nicole
    Schuster, Eva
    Holzer, Barbara
    Fabikan, Hannah
    Weinlinger, Christoph
    Illini, Oliver
    Hochmair, Maximilian
    Zeillinger, Robert
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [22] Dynamic Changes in Cell-Free Circulating Tumor DNA to Track Tumor Response and Risk of Recurrence in Stage III Non-Small Cell Lung Cancer
    Lin, Steven H.
    Xu, Ting
    He, Jianzhong
    Banks, Kimberly
    Lanman, Richard B.
    Sebisanovic, Dragan
    Talasaz, Amir A.
    Lu, Charles
    Buchholz, Thomas
    Hahn, Stephen
    Komaki, Ritsuko U.
    Liao, Zhongxing
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S287 - S287
  • [23] Evaluation of activin A as a novel circulating prognostic marker in non-small cell lung cancer patients
    Rozsas, Anita
    Hoda, Mir Alireza
    Klikovits, Thomas
    Lang, Elisabeth
    Hegedus, Balazs
    Berger, Walter
    Klepetko, Walter
    Grusch, Michael
    Dome, Balazs
    Laszlo, Viktoria
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (19-20) : 763 - 763
  • [24] Neutrophil to Lymphocyte Ratio (NLR) at Diagnosis as a Prognostic Marker in Patients with Stage IV Non-Small Cell Lung Cancer
    Ricardo, Eliza D.
    Da Costa, Alexandre A. B. A.
    De Lima, Vladmir C. C.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S723 - S723
  • [25] Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer
    Park, Seong Yong
    Lee, Hyun-Sung
    Jang, Hee-Jin
    Lee, Geon Kook
    Chung, Kyung Young
    Zo, Jae Ill
    ANNALS OF THORACIC SURGERY, 2011, 91 (06): : 1668 - 1673
  • [26] The prognostic impact of tumor volume on stage I non-small cell lung cancer
    Su, Xiao-Dong
    Xie, Hao-Jun
    Liu, Qian-Wen
    Mo, Yun-Xian
    Long, Hao
    Rong, Tie-Hua
    LUNG CANCER, 2017, 104 : 91 - 97
  • [27] Circulating tumor cell analysis in patients with non-small cell lung cancer
    Kato, T.
    Yamada, K.
    Nokihara, H.
    Fukui, T.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Ohe, Y.
    Koizumi, F.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Detection and application of circulating tumor cell and circulating tumor DNA in the non-small cell lung cancer
    Zhang, Yuting
    Zheng, Hongmei
    Zhan, Yuting
    Long, Mengping
    Liu, Sile
    Lu, Junmi
    Zang, Hongjing
    Fan, Songqing
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (12): : 2377 - 2386
  • [29] Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer
    Ulivi, Paola
    Petracci, Elisabetta
    Marisi, Giorgia
    Baglivo, Sara
    Chiari, Rita
    Billi, Monia
    Canale, Matteo
    Pasini, Luigi
    Racanicchi, Serena
    Vagheggini, Alessandro
    Delmonte, Angelo
    Mariotti, Marita
    Ludovini, Vienna
    Bonafe, Massimiliano
    Crino, Lucio
    Grignani, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [30] Serum autoantibodies as prognostic biomarkers for stage IV non-small cell lung cancer (NSCLC).
    Pergande, Melissa R.
    Piper, Clinton T.
    Fhied, Cristina L.
    Mahon, Brett
    Fidler, Mary J.
    Bonomi, Philip
    Borgia, Jeffrey Allen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345